Arrhythmias & electrophysiology
Management of Rhythm and Conduction Disorders in Cardiac Amyloidosis: A French Nationwide Delphi Study
Authors' conclusion
Approximately 70% of the proposed statements achieved agreement among the experts, reflecting reasonable alignment on anticoagulation therapy, AF management, and implantable cardiac devices. However, the study also highlights the need for personalized, multidisciplinary management of arrhythmias and conduction disorders in CA and emphasizes the need for future research to develop evidence-based guidelines.
Study context
- Population
- French cardiologists and electrophysiologists specializing in cardiac amyloidosis (CA)panel of cardiologists and electrophysiologists, 248 statements evaluated
- Participants
- 56 cardiologists
- Outcome
- Consensus on statements
- Follow-up
- 2 rounds
Methodological details2 rounds
- 2 rounds
Main finding
As reported in the abstract
Consensus achieved on statements
177 out of 248 statements across 2 rounds (71%)
Original publication
Management of Rhythm and Conduction Disorders in Cardiac Amyloidosis: A French Nationwide Delphi Study. JACC Adv. Published 15 February 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →